Home » Biotechnology » Biological Product Manufacturing Market

Biological Product Manufacturing Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Growth Hormones, Beta Interferon, Therapeutic Enzymes) By End User (Hospitals, Specialized Clinics, Government Research Institutes)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

The global biological product manufacturing market is segmented by product type, end-user, and region. Monoclonal antibodies dominate the product type segment, while hospitals lead as the primary end user. North America holds the largest market share, followed by Europe, with the Asia-Pacific region exhibiting high growth potential.

The biological product manufacturing market is driven by rising demands for biopharmaceuticals and advancements in healthcare technologies, fueling the growth of personalized medicine and targeted therapies. However, the market faces restraints such as complex & costly manufacturing processes, stringent regulations, and intellectual property challenges. Nonetheless, there are opportunities for expansion in the global biological product manufacturing market, including expanding the biosimilars sector, developing cell and gene therapies, and untapped potential in emerging markets with improving healthcare infrastructure.

Market Overview

The global biological product manufacturing market has witnessed steady growth in recent years and is expected to grow at a CAGR of XX% between 2023 and 2030. The market was valued at USD XX billion in 2022 and is expected to reach USD XX billion in 2030.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What Are The Main Drivers Of The Global Biological Product Manufacturing Market?

The primary drivers of the global biological product manufacturing market expansion are the increasing demand for biopharmaceuticals and biological products worldwide, driven by the rising incidence of chronic diseases and the need for effective treatments. Moreover, advancements in biotechnology and manufacturing processes, favorable regulatory support, and growing investments in R&D activities by pharmaceutical and biotech companies contribute to the market’s growth.

What Are The Major Challenges Faced By The Global Biological Product Manufacturing Market?

The global biological product manufacturing market faces major challenges, such as complex and costly manufacturing processes, stringent regulatory requirements, and the need for specialized infrastructure and expertise. Additionally, the high development and production costs of biological products, including biopharmaceuticals, present challenges in terms of affordability and accessibility.

What Are The Growth Opportunities In The Global Biological Product Manufacturing Market?

The global biological product manufacturing market presents growth opportunities, such as the expansion of the biosimilars market, the increasing focus on personalized medicine and targeted therapies, and the untapped potential in emerging markets with rising healthcare expenditure. Furthermore, advancements in cell and gene therapies and the growing demand for contract manufacturing organizations (CMOs) specializing in biological product manufacturing offer additional avenues for growth and innovation in the market.

Executive Summary

Overview of the Global Biological Product Manufacturing Market

The biological product manufacturing market produces biopharmaceuticals, vaccines, and other biological products using living organisms or their components. It plays a crucial role in the healthcare industry by providing innovative and effective treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. The market encompasses many biological products, including therapeutic proteins, antibodies, enzymes, and gene therapies. With advancements in biotechnology and manufacturing processes, the global biological product manufacturing market has witnessed significant growth, driven by the increasing demand for biopharmaceuticals and the growing prevalence of chronic diseases worldwide.

Market Definition

The biological product manufacturing industry involves developing, producing, and commercializing biopharmaceuticals and other biological products. Biopharmaceuticals are medicinal products derived from living organisms, including proteins, peptides, vaccines, and monoclonal antibodies. These products are produced using advanced biotechnological processes, such as recombinant DNA technology, cell culture, and fermentation. The manufacturing process includes cell line development, upstream and downstream processing, purification, and formulation. The market also encompasses the manufacturing of vaccines, gene therapies, and other biologically derived products that offer innovative and targeted treatments for a wide range of diseases.

Market Insights

The global demand for biological product manufacturing was valued at USD XX Billion in 2022 and is expected to reach USD XX Billion in 2030, growing at a CAGR of XX% between 2023 and 2030.
Monoclonal antibodies are the leading segment by product type and held over 35% share in terms of value in 2022, while the therapeutic enzymes segment is likely to exhibit the fastest CAGR in the forecast period.
The hospital end-user segment dominates the global demand for biological product manufacturing, holding a significant share of over 40% in 2022, and is expected to grow at a rapid CAGR.
North America dominated the industry in 2022, accounting for more than 44% of global market revenue.
Asia Pacific is projected to register a high revenue CAGR in the forecast period, owing to improved healthcare infrastructure, increased expenditure on biologics development, and a more favorable reimbursement environment in some regional countries.
The market is witnessing a growing focus on personalized medicine and targeted therapies, leading to increased demand for molecular profiling and customized biological products.
The development and manufacturing of cell & gene therapies, including CAR-T cell therapies and gene editing technologies, are emerging as key growth areas in the market.

Segmentation by Product Type

Monoclonal antibodies dominate the segment, contributing to over 35% of the market share in terms of value in 2022. The widespread use of monoclonal antibodies in therapeutic applications, such as cancer treatment and autoimmune disorders, contributes to their market dominance.
The therapeutic enzymes segment is expected to exhibit the fastest CAGR in the projected period. Increasing applications of therapeutic enzymes in various disease treatments, including enzyme replacement therapies, drive the segment’s growth.

Segmentation by End User

The government research institutes segment is projected to post the highest CAGR over the estimated period. These institutions play a key role in research and development activities related to biological products, promoting market growth.
The hospital’s segment led the global market in 2022, holding over 40% share in terms of value. Hospitals serve as key end users for biological products, providing patient care and treatment, leading to substantial demand for biopharmaceuticals and other biological products.

Segmentation by Region

North America dominated the global biological product manufacturing market in 2022, accounting for over 44% of revenue share.
Europe is another prominent global biological product manufacturing market, contributing substantially to the overall market share.
The Asia-Pacific region is experiencing rapid growth, with a high CAGR in the biological product manufacturing industry.
The rest of the World, including regions like the Middle East, Latin America, and Africa, is witnessing the rapid adoption of biological product manufacturing solutions.

The growing demand for biopharmaceuticals and advancements in healthcare technologies primarily drives the global market growth for biological product manufacturing. However, the industry faces complex and costly manufacturing processes, stringent regulations, and intellectual property rights and patent protection challenges.

The United States is leading in the global biological product manufacturing market. It has a well-established biotechnology and pharmaceutical industry, advanced healthcare infrastructure, and research capabilities. The country is home to numerous leading biotech and pharmaceutical companies, fostering innovation and driving the development and manufacturing of biological products. Besides, the United States has a favorable regulatory environment that supports the approval and commercialization of biopharmaceuticals. The U.S. is also a leader in R&D activities, attracting substantial investments in biotechnology and driving advancements in the field. According to ClinicalTrial.Gov, as of July 2022, over 32% of global studies were undertaken in the U.S. alone.

Switzerland is recognized as a major hub for the biopharmaceutical industry and plays a key role in the global biological product manufacturing market. The country has a long-standing reputation for precision engineering, scientific research, and high-quality manufacturing processes. Switzerland has a prominent pharmaceutical sector, with businesses such as Roche, Novartis, and Lonza having a large influence in the global biopharmaceutical market. The country’s favorable business environment, skilled workforce, and commitment to innovation have made it a preferred location for research, development, and manufacturing activities in the biotechnology and pharmaceutical sectors.

Increasing Demands for Biopharmaceuticals and Biological Products

There is a growing need for advanced therapies and treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. Biopharmaceuticals offer targeted and personalized therapies that provide higher efficacy and improved patient outcomes compared to traditional pharmaceuticals. The rise in the prevalence of chronic diseases, advancements in healthcare technologies, and a shift toward precision medicine drive the demand for biopharmaceuticals and biological products. The aging population and increasing healthcare expenditure in many countries also contribute to market growth.

Technological Advancements in Biotechnology and Manufacturing Processes

Innovations in genetic engineering, cell culture techniques, and fermentation processes have enabled the production of complex biological products, including recombinant proteins, monoclonal antibodies, vaccines, and cell and gene therapies. Besides, adopting single-use systems, continuous manufacturing, and automation has improved process efficiency, scalability, and cost-effectiveness. These advancements have increased production capacity, reduced manufacturing times, and enhanced quality control, leading to the market’s overall growth.

Complex and Costly Manufacturing Processes

The complex and costly nature of biological product manufacturing processes is a key limitation in the global market. Manufacturing biological products involves intricate and resource-intensive procedures, including cell line development, upstream and downstream processing, purification, and formulation. These processes require specialized facilities, advanced equipment, and highly skilled personnel, which can lead to high operational costs. Also, ensuring compliance with strict regulatory requirements, such as Good Manufacturing Practices (GMP) and quality control standards, adds to the complexity and cost of manufacturing. These factors limit the entry of new players and hinder market growth.

Personalized Medicine and Targeted Therapies

The global shift towards personalized medicine and targeted therapies represents a major biological product manufacturing market opportunity. There is a growing focus on developing customized treatments based on an individual’s genetic makeup and disease characteristics. This trend creates a demand for molecular profiling and the production of tailored biological products. Advancements in genomics, biomarker identification, and companion diagnostics enable the development of targeted therapies that offer improved efficacy and reduced side effects. The ability to deliver personalized treatments opens up new avenues for growth and innovation in the market.

Competitive Landscape

Key Players

The competitive landscape of the global biological product manufacturing market is characterized by a mix of established pharmaceutical companies, biotechnology firms, and contract manufacturing organizations (CMOs). Some of the major players in the market and their market share are as follows:

Lonza
Advanced Life Sciences Holdings Inc
Pfizer Inc
Johnson & Johnson
Invitrogen
Amgen
Abbott Laboratories
Piramal Healthcare
Shenhua Group Corp. Ltd

These key players in the market are actively focused on R&D operations to develop innovative biological products and expand their product portfolios. They also invest in advanced manufacturing technologies and processes to improve production efficiency and meet the emerging demand for biopharmaceuticals. Collaborations, partnerships, and strategic acquisitions are common strategies companies employ to strengthen their market position and expand their geographic presence. The market is highly competitive, with companies striving to differentiate themselves through product innovation, cost-effectiveness, and a strong focus on meeting customer needs regarding product quality and supply chain reliability.

For example, in March 2023, Sweden-based Simris Alg AB collaborated with Lonza to research and manufacture antibody-drug conjugates. Such collaborations are projected to boost market expansion in Sweden.

Likewise, Lonza expanded its presence in the United States in February 2023 by opening a new laboratory focused on researching pharmaceuticals in the early phases of clinical trials.

Lonza also collaborated with biotechnology company Touchlight in September 2022 to widen its product portfolio with different sources of DNA for developing mRNA. Touchlight formed this alliance to acquire access to Lonza’s unique doggy bone DNA (dbDNA) technology.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

The biological product manufacturing market is experiencing rapid growth due to increasing demand for biopharmaceuticals and biological products worldwide.
Market segmented by product type, end-user, and region.
Monoclonal antibodies dominate the product type segment, while hospitals are the leading end user.
North America holds the largest market share, followed by Europe, with the Asia-Pacific region exhibiting high growth potential.
Complex and costly manufacturing processes pose challenges to market growth.
Technological advancements in biotechnology and manufacturing processes enhance production efficiency and scalability.
The expansion of the biosimilars market and the untapped potential in emerging markets present growth opportunities in the industry.

Future Outlook

Pharmaceutical and biotech firms invest heavily in research and development activities to discover and develop new biological products.
The prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, is fueling the demand for biological products for effective treatments.
Increasing healthcare expenditure and growing awareness of advanced therapies in emerging markets, particularly in Asia-Pacific and Latin America, provide untapped opportunities for market expansion.

Segmentation

By Product Type
- Monoclonal Antibodies
- Recombinant Proteins
- Growth Hormones
- Beta Interferon
- Therapeutic Enzymes
By End User
- Hospitals
- Specialized Clinics
- Government Research Institutes
By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Biological Product Manufacturing Market
2.2. Global Biological Product Manufacturing Market, By Product Type
2.3. Global Biological Product Manufacturing Market, By End User
2.4. Global Biological Product Manufacturing Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Biological Product Manufacturing Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. End User
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Biological Product Manufacturing Market, By Product Type
7.1. Global Biological Product Manufacturing Market Overview, by Product Type
7.1.1. Global Biological Product Manufacturing Market Revenue Share, By Product Type, 2022 Vs 2030 (in %)
7.2. Monoclonal Antibodies
7.2.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
7.3. Recombinant Proteins
7.3.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
7.4. Growth Hormones
7.4.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
7.5. Beta Interferon
7.5.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
7.6. Therapeutic Enzymes
7.6.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)

8. Global Biological Product Manufacturing Market, by End User, 2017-2030 (US$ Bn)
8.1. Global Biological Product Manufacturing Market Overview, by End User
8.1.1. Global Biological Product Manufacturing Market, By End User, 2022 vs 2030 (in%)
8.2. Specialized Clinics
8.2.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
8.3. Hospitals
8.3.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)
8.4. Government Research Institutes
8.4.1. Global Biological Product Manufacturing Market, By Region, 2017-2030 (US$ Bn)

9. Global Biological Product Manufacturing Market, By Region
9.1. Global Biological Product Manufacturing Market Overview, by Region
9.1.1. Global Biological Product Manufacturing Market, By Region, 2022 vs 2030 (in%)
9.2. Product Type
9.2.1. Global Biological Product Manufacturing Market, By Product Type, 2017-2030 (US$ Bn)
9.3. End User
9.3.1. Global Biological Product Manufacturing Market, By End User, 2017-2030 (US$ Bn)

10. North America Biological Product Manufacturing Market Analysis
10.1. North America Biological Product Manufacturing Market, by Product Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Biological Product Manufacturing Market, by End User, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Biological Product Manufacturing Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Biological Product Manufacturing Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
10.3.3.3. Canada Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)

11. Europe Biological Product Manufacturing Market Analysis
11.1. Europe Biological Product Manufacturing Market, by Product Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Biological Product Manufacturing Market, by End User, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Biological Product Manufacturing Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Biological Product Manufacturing Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.2.3. Germany Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.3.3. France Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.4.3. UK Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.5.3. Italy Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.6.3. Spain Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)

12. Asia Pacific Biological Product Manufacturing Market Analysis
12.1. Asia Pacific Biological Product Manufacturing Market, by Product Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Biological Product Manufacturing Market, by End User, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Biological Product Manufacturing Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Biological Product Manufacturing Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.2.3. China Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.3.3. Japan Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.4.3. India Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)

13. Latin America Biological Product Manufacturing Market Analysis
13.1. Latin America Biological Product Manufacturing Market, by Product Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Biological Product Manufacturing Market, by End User, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Biological Product Manufacturing Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Biological Product Manufacturing Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)

14. Middle East and Africa Biological Product Manufacturing Market Analysis
14.1. Middle East and Africa Biological Product Manufacturing Market, by Product Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Biological Product Manufacturing Market, by End User, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Biological Product Manufacturing Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Biological Product Manufacturing Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Biological Product Manufacturing Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Biological Product Manufacturing, By Product Type, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Biological Product Manufacturing, By End User, 2017-2030 (US$ Bn)

15. Company Profiles
15.1. Lonza
15.1.1. Company Overview
15.1.2. Products/Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Advanced Life Sciences Holdings Inc
15.3. Pfizer Inc
15.4. Johnson & Johnson
15.5. Invitrogen
15.6. Amgen
15.7. Abbott Laboratories
15.8. Piramal Healthcare
15.9. Shenhua Group Corp. Ltd

List of Figures
FIG. 1 Global Biological Product Manufacturing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biological Product Manufacturing Market Segmentation
FIG. 4 Global Biological Product Manufacturing Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Biological Product Manufacturing Market, by End User, 2022 (US$ Bn)
FIG. 6 Global Biological Product Manufacturing Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Product Type, 2022
FIG. 8 Attractive Investment Proposition, by End User, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Biological Product Manufacturing Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Biological Product Manufacturing Market Manufacturers, 2022
FIG. 12 Global Biological Product Manufacturing Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 13 Global Biological Product Manufacturing Market, by Monoclonal Antibodies, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Biological Product Manufacturing Market, by Recombinant Proteins, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Biological Product Manufacturing Market, by Growth Hormones, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Biological Product Manufacturing Market, by Beta Interferon, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Biological Product Manufacturing Market, by Therapeutic Enzymes, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Biological Product Manufacturing Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 19 Global Biological Product Manufacturing Market, by Specialized Clinics, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Biological Product Manufacturing Market, by Hospitals, 2017-2030 (US$ Bn)
FIG. 21 Global Biological Product Manufacturing Market, by Government Research Institutes, 2017-2030 (US$ Bn)
FIG. 22 North America Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 23 U.S. Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 24 Canada Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 25 Europe Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 26 Germany Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 27 France Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 28 U.K. Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 29 Italy Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 30 Spain Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 31 Rest of Europe Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 32 Asia Pacific Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 33 China Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 34 Japan Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 35 India Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 36 South Korea Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 37 South-East Asia Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Asia Pacific Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 39 Latin America Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 40 Brazil Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 41 Mexico Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 42 Rest of Latin America Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 43 Middle East & Africa Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 44 GCC Countries Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 45 South Africa Biological Product Manufacturing Market, 2017-2030 (US$ Bn)
FIG. 46 Rest of Middle East and Africa Biological Product Manufacturing Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Biological Product Manufacturing Market
TABLE 2 Global Biological Product Manufacturing Market: Market Drivers Impact Analysis
TABLE 3 Global Biological Product Manufacturing Market: Market Restraints Impact Analysis
TABLE 4 Global Biological Product Manufacturing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Biological Product Manufacturing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Biological Product Manufacturing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Biological Product Manufacturing Market, by Monoclonal Antibodies, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Biological Product Manufacturing Market, by Monoclonal Antibodies, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Biological Product Manufacturing Market, by Recombinant Proteins, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Biological Product Manufacturing Market, by Recombinant Proteins, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Biological Product Manufacturing Market, by Growth Hormones, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Biological Product Manufacturing Market, by Growth Hormones, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Biological Product Manufacturing Market, by Beta Interferon, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Biological Product Manufacturing Market, by Beta Interferon, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Biological Product Manufacturing Market, by Therapeutic Enzymes, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Biological Product Manufacturing Market, by Therapeutic Enzymes, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Biological Product Manufacturing Market, by Specialized Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Biological Product Manufacturing Market, by Specialized Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Biological Product Manufacturing Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Biological Product Manufacturing Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Biological Product Manufacturing Market, by Government Research Institutes, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Biological Product Manufacturing Market, by Government Research Institutes, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 24 Global Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 25 Global Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 26 Global Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 27 Global Biological Product Manufacturing Market, by Region, 2017-2022 (US$ Bn)
TABLE 28 Global Biological Product Manufacturing Market, by Region, 2023-2030 (US$ Bn)
TABLE 29 North America Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 30 North America Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 31 North America Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 32 North America Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 33 North America Biological Product Manufacturing Market, by Country, 2017-2022 (US$ Bn)
TABLE 34 North America Biological Product Manufacturing Market, by Country, 2023-2030 (US$ Bn)
TABLE 35 United States Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 36 United States Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 37 United States Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 38 United States Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 39 Canada Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 40 Canada Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 41 Canada Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 42 Canada Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 43 Mexico Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 44 Mexico Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 45 Mexico Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 46 Mexico Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 47 Europe Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 48 Europe Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 49 Europe Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 50 Europe Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 51 Europe Biological Product Manufacturing Market, by Country, 2017-2022 (US$ Bn)
TABLE 52 Europe Biological Product Manufacturing Market, by Country, 2023-2030 (US$ Bn)
TABLE 53 Germany Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 54 Germany Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 55 Germany Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 56 Germany Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 57 France Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 58 France Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 59 France Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 60 France Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 61 United Kingdom Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 62 United Kingdom Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 63 United Kingdom Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 64 United Kingdom Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 65 Italy Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 66 Italy Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 67 Italy Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 68 Italy Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 69 Spain Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 70 Spain Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 71 Spain Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 72 Spain Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 73 Rest of Europe Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 74 Rest of Europe Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 75 Rest of Europe Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 76 Rest of Europe Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 77 Asia Pacific Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 78 Asia Pacific Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 79 Asia Pacific Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 80 Asia Pacific Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 81 China Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 82 China Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 83 China Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 84 China Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 85 Japan Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 86 Japan Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 87 Japan Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 88 Japan Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 89 India Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 90 India Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 91 India Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 92 India Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 93 South Korea Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 94 South Korea Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 95 South Korea Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 96 South Korea Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 97 South-East Asia Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 98 South-East Asia Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 99 South-East Asia Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 100 South-East Asia Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 101 Rest of Asia Pacific Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 102 Rest of Asia Pacific Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 103 Rest of Asia Pacific Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 104 Rest of Asia Pacific Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 105 Latin America Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 106 Latin America Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 107 Latin America Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 108 Latin America Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 109 Brazil Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 110 Brazil Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 111 Brazil Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 112 Brazil Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 113 Argentina Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 114 Argentina Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 115 Argentina Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 116 Argentina Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 117 Rest of Latin America Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 118 Rest of Latin America Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 119 Rest of Latin America Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 120 Rest of Latin America Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 121 Middle East and Africa Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 122 Middle East and Africa Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 123 Middle East and Africa Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 124 Middle East and Africa Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 125 GCC Countries Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 126 GCC Countries Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 127 GCC Countries Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 128 GCC Countries Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 129 South Africa Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 130 South Africa Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 131 South Africa Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 132 South Africa Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)
TABLE 133 Rest of Middle East and Africa Biological Product Manufacturing Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 134 Rest of Middle East and Africa Biological Product Manufacturing Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 135 Rest of Middle East and Africa Biological Product Manufacturing Market, by End User, 2017-2022 (US$ Bn)
TABLE 136 Rest of Middle East and Africa Biological Product Manufacturing Market, by End User, 2023-2030 (US$ Bn)

Frequently Asked Questions:

What is the current size of the global biological product manufacturing market?

The global biological product manufacturing market was valued at USD XX Billion in 2022.

What is the expected growth rate of the biological product manufacturing market between 2023 and 2030?

The biological product manufacturing market is expected to grow at a CAGR of XX% between 2023 and 2030, reaching USD XX Billion in 2030.

Which segment is leading the market share in terms of product type?

Monoclonal antibodies are the leading segment by product type, holding over 35% share in terms of value in 2022.

Which end-user segment governs the global demand for biological product manufacturing?

The hospital segment governs the global demand for biological product manufacturing, holding a massive share of over 40% in 2022.

Which product type segment will post the highest CAGR in the forecast period?

The therapeutic enzymes segment will post the highest CAGR in the projected period.

Which region is fueling the growth of the biological product manufacturing industry?

Asia Pacific is fueling the rapid growth of the biological product manufacturing industry, with an over one-third share in 2022.

Who are the major global biological product manufacturing market players?

Advanced Life Sciences Holdings Inc, Invitrogen, Shenhua Group Corp. Ltd, and Lonza are the top market players. Other major players include Pfizer Inc, Amgen, Piramal Healthcare, and Johnson & Johnson.

What are the major market drivers of the biological product manufacturing industry?

The major market drivers are the increasing demand for biopharmaceuticals and biological products worldwide and advancements in healthcare technologies.

What are the major market restraints of the biological product manufacturing industry?

The major market restraints are the complex and costly manufacturing processes, stringent regulatory requirements, and intellectual property rights and patent protection challenges.

What are the major market opportunities of the biological product manufacturing industry?

The major market opportunities of the biological product manufacturing industry include expanding the biosimilars market, growing focus on personalized medicine and targeted therapies, and developing and manufacturing cell and gene therapies.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –